Report - Targeting MET in cancer: rationale and progress · MET and its physiological ligand hepatocyte growth factor/scatter factor (HGF/SF) were discovered in the . mid‑1980s as a result

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form